Rapid adoption expected of Boston Scientific's Farapulse, Medtronic ICDs have life-saving potential

29/08/2023 11 min
Rapid adoption expected of Boston Scientific's Farapulse, Medtronic ICDs have life-saving potential

Listen "Rapid adoption expected of Boston Scientific's Farapulse, Medtronic ICDs have life-saving potential"

Episode Synopsis

SmileDirectClub and Align Technology are in a legal proceeding from a previous partnership. Fast Five hosts Sean Whooley and Danielle Kirsh discuss SDC's plans to appeal a court order that said it has to pay Align Technology $63 million. In today's episode, find out more about the proceeding and the SmileDirectClub's appeal.

GE Healthcare has unveiled its latest wireless, handheld ultrasound device. Whooley explains what the device does, how accompanying digital tools help clinicians and what executives think about this unveiling. 

Diabetes news and continuous glucose monitors continue to innovate. This week, Insulet launched its Omnipod 5 in Germany and announced when it expects a full European launch. Whooley outlines the regulatory pathway Omnipod 5 took to get to the Germany launch and how patients and executives feel about its entry into Europe.

This week, we have study data from the European Society of Cardiology (ESC) in Amsterdam. Medtronic posted study results that demonstrated ICDs could prevent sudden cardiac death. Hear some of the data points from the study.

Boston Scientific also posted results from ESC. Its Farapulse pulsed-field ablation device had positive results – and analysts now expect FDA approval and rapid adoption on the U.S. market. Listen to today's episode for more details.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

More episodes of the podcast Fast Five Medtech News Podcast